Bavarian Nordic A/S announced the appointment of Dr. Laurence De Moerlooze to the position of Executive Vice President and Chief Medical Officer. Dr. De Moerlooze joins Bavarian Nordic from Takeda Vaccines, where she has served since 2017 as Vice President and Global Program Lead for vaccines against Zika virus and Norovirus. Prior to joining Takeda, she worked at GlaxoSmithKline (GSK) for more than 15 years, holding various leading roles in medical affairs and vaccine development working with numerous life-saving vaccines including Rabipur/Rabavert and Encepur. Dr. De Moerlooze will take up the position in April 2020.